Nonoperating Income (Expense) in USD of Phathom Pharmaceuticals, Inc. from Q1 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Phathom Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2018 to Q3 2025.
  • Phathom Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2025 was -$14.7M, a 0.53% increase year-over-year.
  • Phathom Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2025 was -$61.1M, a 18.5% decline year-over-year.
  • Phathom Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2024 was -$56.9M, a 65.9% decline from 2023.
  • Phathom Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was -$34.3M, a 35.6% decline from 2022.
  • Phathom Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was -$25.3M, a 187% decline from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)

Phathom Pharmaceuticals, Inc. Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$61.1M -$14.7M +$79K +0.53% Jul 1, 2025 Sep 30, 2025 10-Q 2025-10-30
Q2 2025 -$61.2M -$15.9M -$1.74M -12.3% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-07
Q1 2025 -$59.4M -$15.5M -$2.56M -19.8% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-01
Q4 2024 -$56.9M -$15M -$5.34M -55.1% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-06
Q3 2024 -$51.5M -$14.8M -$7.2M -94.9% Jul 1, 2024 Sep 30, 2024 10-Q 2025-10-30
Q2 2024 -$44.3M -$14.1M -$4.88M -52.7% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-07
Q1 2024 -$39.4M -$12.9M -$5.16M -66.7% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-01
Q4 2023 -$34.3M -$9.7M -$1.29M -15.3% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-06
Q3 2023 -$33M -$7.58M +$978K +11.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$34M -$9.26M -$3.71M -66.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$30.3M -$7.74M -$4.98M -180% Jan 1, 2023 Mar 31, 2023 10-Q/A 2024-06-14
Q4 2022 -$25.3M -$8.41M -$5.62M -202% Oct 1, 2022 Dec 31, 2022 10-K/A 2024-06-14
Q3 2022 -$19.7M -$8.56M -$5.04M -143% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$14.6M -$5.56M -$4.32M -351% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$10.3M -$2.76M -$1.5M -119% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$8.8M -$2.79M -$1.5M -117% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-28
Q3 2021 -$7.3M -$3.53M -$2.25M -176% Jul 1, 2021 Sep 30, 2021 10-Q/A 2022-11-09
Q2 2021 -$5.05M -$1.23M -$153K -14.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 -$4.9M -$1.26M -$1.49M -638% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$3.4M -$1.28M +$81M +98.4% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-30
Q3 2020 -$84.4M -$1.28M +$60.6M +97.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$145M -$1.08M +$3.67M +77.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 -$149M $234K +$259K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 -$149M -$82.3M -$82.3M -249333% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-30
Q3 2019 -$66.6M -$61.8M -$61.8M -280945% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-30
Q2 2019 -$4.83M -$4.75M -$4.74M Apr 1, 2019 Jun 30, 2019 10-K 2021-03-30
Q1 2019 -$85K -$25K -$22K Jan 1, 2019 Mar 31, 2019 10-K 2021-03-30
Q4 2018 -$63K -$33K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-19
Q3 2018 -$22K Jul 1, 2018 Sep 30, 2018 10-K 2020-03-19
Q2 2018 -$5K* Apr 1, 2018 Jun 30, 2018 10-K 2020-03-19
Q1 2018 -$3K* Jan 1, 2018 Mar 31, 2018 10-K 2020-03-19

Phathom Pharmaceuticals, Inc. Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$56.9M -$22.6M -65.9% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-06
2023 -$34.3M -$9M -35.6% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-06
2022 -$25.3M -$16.5M -187% Jan 1, 2022 Dec 31, 2022 10-K/A 2024-06-14
2021 -$8.8M -$5.4M -159% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-28
2020 -$3.4M +$146M +97.7% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-01
2019 -$149M -$149M -236275% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-30
2018 -$63K Jan 1, 2018 Dec 31, 2018 10-K 2020-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.